Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer

Table 2 Distributions of the EQ-5D-5L index and subscale scores of EORTC QLQ-C30 and FACT-G

	Minimum	5%	25%	Median	75%	95%	Maximum
EORTC QLQ-C30 analysis
EQ-5D-5L index (Japan)	− 0.025	0.437	0.691	0.823	0.895	1	1
EORTC QLQ-C30
Physical functioning	0	33.3	66.7	86.7	93.3	100	100
Role functioning	0	0	66.7	83.3	100	100	100
Emotional functioning	0	44.4	75	83.3	100	100	100
Cognitive functioning	0	33.3	66.7	83.3	100	100	100
Social functioning	0	33.3	66.7	83.3	100	100	100
Global health status	0	16.7	50	66.7	83.3	100	100
Fatigue	0	0	22.2	33.3	55.6	77.8	100
Nausea and vomiting	0	0	0	0	16.7	33.3	100
Pain	0	0	0	16.7	33.3	66.7	100
Dyspnea	0	0	0	33.3	33.3	100	100
Insomnia	0	0	0	33.3	33.3	66.7	100
Appetite loss	0	0	0	0	33.3	100	100
Constipation	0	0	0	33.3	33.3	66.7	100
Diarrhea	0	0	0	0	33.3	66.7	100
Financial difficulties	0	0	0	33.3	33.3	100	100
FACT-G analysis
EQ-5D-5L index (Japan)	− 0.025	0.436	0.691	0.823	0.895	1	1
FACT-G
Physical well-being	1	9	16	22	25	28	28
Social/family well-being	0	5	14	18	22	26.8	28
Emotional well-being	0	7	13	17	20	23	24
Functional well-being	0	6	13	17	22	27	28

EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; FACT-G, Functional Assessment of Cancer Therapy General

ISSN: 1477-7525